Ruckdeschel, A; Sabrina, K; Topp, MS; Greil, R; Melchardt, T; Lenz, G; Kerkhoff, A; Shumilov, E; Hess, G; Baumgaertner, M; Thurner, L; Kos, IA; Mayer, S; Ayuk, FA; Krause, R; Herling, M; Vucinic, V; Chapuy, C; Illerhaus, G; Knott, M; Viardot, A; Grunenberg, A; Dietrich, S; Caille, L; Tometten, MC; Rosa, H; Scholz, J; Mueller, F; Prochazka, K; Chapuy, B; Böckle, D; von Tresckow, B; Schub, N; Gelbrich, G; Einsele, H; Duell, J.
Tafasitamab and Lenalidomide in Relapsed/Refractory B-Cell Lymphoma: A Multicenter Retrospective Real-World-Study of Patients from Germany and Austria
BLOOD. 2023; 142:
Doi: 10.1182/blood-2023-185992
Web of Science
FullText
FullText_MUG